Home » Generic Nizatidine Antacid Wins Approval for Amneal
Generic Nizatidine Antacid Wins Approval for Amneal
Amneal Pharmaceuticals has received FDA approval
to market the first generic nizatidine oral solution to treat heartburn, gastroesophageal reflux disease and conditions associated with excess acid secretion.
Nizatidine 15 mg/mL, a generic H2-blocker/antacid, also is approved to prevent and treat ulcers, according to the company’s website.
Generic Line
Generic Line
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May